📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer. (2024)

First Author: Sampson J

Attributed to: Understanding and targeting oncogenic biomolecular condensates of ALK kinase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-024-07272-7

PubMed Identifier: 39695132

Publication URI: http://europepmc.org/abstract/MED/39695132

Type: Journal Article/Review

Volume: 15

Parent Publication: Cell death & disease

Issue: 12